B. Metzler seel. Sohn & Co’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
DGM
OAG
B. Metzler seel. Sohn & Co's INSM Position: Q2 2026 in Review
B. Metzler seel. Sohn & Co increased its Insmed (INSM) stake by 3.3% in Q2 2026, buying an estimated $155K and bringing the position to 40,521 shares worth $4.32M. The position accounts for 0.04% of the portfolio, ranked #269.
B. Metzler seel. Sohn & Co first reported a position in INSM in Q1 2022 and has held it in 17 quarters since. The position peaked at $6.42M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- B. Metzler seel. Sohn & Co held 40,521 shares of Insmed worth $4.32M as of Q2 2026.
- B. Metzler seel. Sohn & Co bought 1,278 Insmed shares in Q2 2026, an estimated $155K.
- Insmed made up 0.04% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #269 holding.
- B. Metzler seel. Sohn & Co first reported a position in Insmed in Q1 2022 and has held it in 17 quarters since.
- B. Metzler seel. Sohn & Co's Insmed position peaked at $6.42M in Q1 2026.
- 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.